AATD is a genetic condition that manifests as lung and liver diseases. It arises due to a lack of the alpha-1 antitrypsin (AAT) protein, primarily produced in the liver to safeguard the lungs from harm. When there is not enough of this vital protein, the lungs become susceptible to inflammation and damage, which can lead to health issues like emphysema and chronic obstructive pulmonary disease (COPD).

In this insights report, we provide prevalence statistics, then explore AATD's impact, potential treatment options, and the genetic component of AATD.

Download to learn more.